Temporal trends in ischemic stroke and female sex as a risk modifier in atrial fibrillation: insights from non-anticoagulated Asian patients in a nationwide cohort study

缺血性卒中的时间趋势及女性作为房颤风险因素的作用:来自一项全国性队列研究的未接受抗凝治疗的亚洲患者的启示

阅读:2

Abstract

BACKGROUND: Previous studies from Western populations have reported changing temporal trends in ischemic stroke (IS) incidence in females with atrial fibrillation (AF) when compared with males. Nationwide data on such temporal trends in AF-related IS incidence by sex are limited in Asian populations. METHODS: This population-based retrospective cohort study included patients with incident AF diagnosed between 2005 and 2016 from the Korean National Health Insurance Service. Patients with valvular heart disease, prior IS, or anticoagulant use were excluded. Incidence rates (IRs) per 100 person-years and hazard ratios (HRs) for IS were calculated by Fine and Gray competing risk regression. FINDINGS: After exclusions, 290,081 females (mean age: 64.4 years, SD 16.3) and 338,100 males (mean age: 60.1 years, SD 14.9) were included. The mean follow-up duration was 5.7 (SD 4.1) years. At baseline, the CHA(2)DS(2)-VA scores were higher in females than in males (2.0 vs. 1.6, P < 0.0001). IRs for IS declined over time in both sexes (P for trend < 0.0001). The IS incidence in females compared to males was significantly higher in 2005-2006 (1.55 vs. 1.40; HR(unadj): 1.12, 95% confidence interval: 1.06-1.19); however, it was no longer significant in 2015-2016 (1.20 vs. 1.17; HR(unadj): 1.03, 95% confidence interval: 0.99-1.08). The reduction in relative risk primarily originated from the subgroup with CHA(2)DS(2)-VA scores 0-1. Females with CHA(2)DS(2)-VA scores ≥3 consistently showed higher IRs for IS compared to males regardless of adjustment. INTERPRETATION: Sex differences in IS incidence decreased over calendar-year intervals, mainly in low-risk patients with AF. The persistently high IS incidence in high-risk females with AF suggests that sex still remains an important risk modifier. FUNDING: Patient-Centered Clinical Research Coordinating Center, Republic of Korea.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。